Alnylam Pharmaceuticals, Inc.

NasdaqGS:ALNY Stock Report

Market Cap: US$30.2b

Alnylam Pharmaceuticals, Inc. Company Information

Alnylam Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Alnylam Pharmaceuticals, Inc.
  • Ticker: ALNY
  • Exchange: NasdaqGS
  • Founded: 2002
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$30.216b
  • Shares Outstanding: 128.98m
  • Website: https://www.alnylam.com

Number of Employees


Location

  • Alnylam Pharmaceuticals, Inc.
  • 675 West Kendall Street
  • Henri A. Termeer Square
  • Cambridge
  • Massachusetts
  • 02142
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALNYNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMay 2004
DULDB (Deutsche Boerse AG)YesCommon StockDEEURMay 2004
0HD2LSE (London Stock Exchange)YesCommon StockGBUSDMay 2004
ALNY *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNMay 2004
A1LN34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 20 REPR 1 COM NPVBRBRLOct 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 15:59
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.